Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2020-02-07 00:11 2020-02-04 KZR Kezar Life Sciences, Inc. Morningside Venture Investments Ltd 10% owner Pharmaceutical Preparations BUY $2.60 3,800,000 $9,880,000 6,109,052 +164.6%
2020-02-06 19:27 2020-02-04 ARQT Arcutis Biotherapeutics Inc. Heron Patrick J Director, 10% owner Pharmaceutical Preparations BUY $17.00 500,000 $8,500,000 10,542,790 +5.0%
2020-02-06 18:29 2020-02-04 ARQT Arcutis Biotherapeutics Inc. Frazier Life Sciences VIII, L.P. 10% owner Pharmaceutical Preparations BUY $17.00 500,000 $8,500,000 10,542,790 +5.0%
2020-02-07 01:08 2020-02-06 EPD ENTERPRISE PRODUCTS PARTNERS L.P. WILLIAMS RANDA DUNCAN Director, 10% owner Natural Gas Transmission BUY $26.05 50,000 $1,302,640 4,483,218 +1.1%
2020-02-06 01:04 2020-02-03 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $134.65 96,007 $12,927,669 21,338,237 +0.5%
2020-02-06 02:02 2020-02-03 BDTX Black Diamond Therapeutics, Inc. Versant Venture Capital VI, L.P. 10% owner Biological Products, (No Diagnostic Substances) BUY $19.00 894,736 $16,999,984 1,206,603 +286.9%
2020-02-06 01:58 2020-02-03 BDTX Black Diamond Therapeutics, Inc. Shah Rajeev M. Director Biological Products, (No Diagnostic Substances) BUY $19.00 1,000,000 $19,000,000 353,814 +100.0%
2020-02-06 01:55 2020-02-03 BDTX Black Diamond Therapeutics, Inc. Behbahani Ali Director Biological Products, (No Diagnostic Substances) BUY $19.00 800,000 $15,200,000 3,448,757 +30.2%
2020-02-06 01:43 2020-02-03 CERC Avalo Therapeutics, Inc. ARMISTICE CAPITAL, LLC Director, 10% owner Pharmaceutical Preparations BUY $3.98 1,256,282 $5,000,002 675,000 +100.0%
2020-02-06 01:39 2020-02-03 BRPM Alta Equipment Group Inc. B. Riley Financial, Inc. 10% owner Wholesale-Industrial Machinery & Equipment BUY $10.21 108,333 $1,106,578 4,241,058 +2.6%
2020-02-06 01:59 2020-02-03 BDTX Black Diamond Therapeutics, Inc. Bolzon Bradley J PhD Director Biological Products, (No Diagnostic Substances) BUY $19.00 894,736 $16,999,984 1,206,603 +286.9%
2020-02-06 01:28 2020-02-04 T AT&T INC. LUCZO STEPHEN J Director Telephone Communications (No Radiotelephone) BUY $37.60 100,000 $3,760,380 164,000 +156.3%
2020-02-06 01:16 2020-02-05 EPD ENTERPRISE PRODUCTS PARTNERS L.P. WILLIAMS RANDA DUNCAN Director, 10% owner Natural Gas Transmission BUY $26.40 50,000 $1,320,135 4,470,718 +1.1%
2020-02-05 00:30 2020-01-31 PKD N/A HIGHBRIDGE CAPITAL MANAGEMENT LLC 10% owner Other BUY $17.06 88,589 $1,511,674 1,743,572 +5.4%
2020-02-05 00:28 2020-01-31 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $130.75 126,609 $16,553,709 21,242,230 +0.6%
2020-02-05 02:27 2020-01-31 PBF PBF Energy Inc. Inversora Carso, S.A. de C.V. 10% owner, Other Petroleum Refining BUY $26.77 263,471 $7,052,249 21,595,901 +1.2%
2020-02-05 01:27 2020-02-03 ARQT Arcutis Biotherapeutics Inc. SILVERSTEIN JONATHAN Director, 10% owner Pharmaceutical Preparations BUY $17.00 558,888 $9,501,096 176,500 +100.0%
2020-02-04 16:00 2020-02-03 ALBO N/A PERCEPTIVE ADVISORS LLC 10% owner Other BUY $21.00 255,809 $5,371,989 1,960,139 +15.0%
2020-02-05 00:26 2020-01-31 SAFE N/A ISTAR INC. 10% owner Other BUY $46.24 45,000 $2,080,800 31,376,502 +0.1%
2020-02-05 00:52 2020-01-31 PGEN PRECIGEN, INC. KIRK RANDAL J Director, Officer, 10% owner - Executive Chairman Pharmaceutical Preparations BUY $5.86 5,972,696 $34,999,999 182,200 +100.0%
2020-02-05 01:25 2020-02-04 EPD ENTERPRISE PRODUCTS PARTNERS L.P. WILLIAMS RANDA DUNCAN Director, 10% owner Natural Gas Transmission BUY $26.15 50,000 $1,307,675 4,458,218 +1.1%
2020-02-05 01:30 2020-02-03 ARQT Arcutis Biotherapeutics Inc. ORBIMED ADVISORS LLC Director, 10% owner Pharmaceutical Preparations BUY $17.00 558,888 $9,501,096 176,500 +100.0%
2020-02-05 04:16 2020-01-31 AMRS N/A DOERR L JOHN Director, 10% owner Other BUY $2.87 10,505,652 $30,151,221 53,210,862 +24.6%
2020-02-04 00:45 2020-01-30 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $131.51 159,055 $20,917,132 21,115,621 +0.8%
2020-02-03 23:20 2020-01-30 N-A Crescent Capital BDC, Inc. UFCW-Northern California Employers Joint Pension Plan 10% owner Other BUY $19.56 343,178 $6,711,532 4,228,985 +8.8%
2020-02-04 01:11 2020-01-30 N/A Blackstone Secured Lending Fund Universities Superannuation Scheme Ltd as sole corporate trustee for Universities Superannuation Scheme Other Other BUY $26.14 1,606,733 $42,000,000 7,545,151 +27.1%
2020-02-03 21:35 2020-01-30 PPR Saba Capital Income & Opportunities Fund Saba Capital Management, L.P. 10% owner Other BUY $5.14 1,318,243 $6,775,769 31,728,463 +4.3%
2020-02-04 01:07 2020-01-30 TRN TRINITY INDUSTRIES INC Boze Brandon B Director, 10% owner, Other Railroad Equipment BUY $20.57 259,079 $5,329,825 25,883,117 +1.0%
2020-02-04 01:02 2020-01-30 LJPC N/A TANG KEVIN C Director, 10% owner Other BUY $6.76 169,770 $1,146,966 8,080,345 +2.1%
2020-02-04 00:41 2020-02-03 EPD ENTERPRISE PRODUCTS PARTNERS L.P. WILLIAMS RANDA DUNCAN Director, 10% owner Natural Gas Transmission BUY $25.62 200,000 $5,123,640 4,445,718 +4.7%
2020-02-03 21:25 2020-02-03 BDTX Black Diamond Therapeutics, Inc. Flynn James E 10% owner, Other Biological Products, (No Diagnostic Substances) BUY $19.00 400,000 $7,600,000 778,790 +105.6%
2020-02-01 00:39 2020-01-29 PKD N/A HIGHBRIDGE CAPITAL MANAGEMENT LLC 10% owner Other BUY $17.63 92,299 $1,626,945 1,654,983 +5.9%
2020-02-01 00:55 2020-01-29 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $135.70 73,295 $9,945,890 20,956,566 +0.4%
2020-01-31 14:01 2020-01-30 ANTM Elevance Health, Inc. BOUDREAUX GAIL Director, Officer - President and CEO Hospital & Medical Service Plans BUY $263.70 7,600 $2,004,152 26,556 +40.1%
2020-01-31 00:54 2020-01-28 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $134.99 66,605 $8,991,102 20,883,271 +0.3%
2020-01-30 19:09 2020-01-30 N-A Crescent Capital BDC, Inc. Texas County & District Retirement System 10% owner Other BUY $19.56 408,545 $7,989,919 5,001,753 +8.9%
2020-01-30 19:29 2020-01-28 PPR Saba Capital Income & Opportunities Fund Saba Capital Management, L.P. 10% owner Other BUY $5.12 581,613 $2,977,859 30,410,220 +1.9%
2020-01-31 04:24 2020-01-28 NOG NORTHERN OIL & GAS, INC. Rowling Robert B. 10% owner Crude Petroleum & Natural Gas BUY $1.67 3,364,000 $5,632,345 80,071,101 +4.4%
2020-01-31 00:47 2020-01-28 SAFE N/A ISTAR INC. 10% owner Other BUY $46.64 45,000 $2,098,800 31,331,502 +0.1%
2020-01-30 23:46 2020-01-29 CRGS N/A GOLISANO B THOMAS 10% owner Other BUY $125,000.00 37,500 $4,687,500,000 37,500 +100.0%
2020-01-30 00:50 2020-01-27 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $134.50 110,433 $14,853,404 20,816,666 +0.5%
2020-01-30 00:56 2020-01-27 TRN TRINITY INDUSTRIES INC Boze Brandon B Director, 10% owner, Other Railroad Equipment BUY $20.85 147,109 $3,067,605 25,624,038 +0.6%
2020-01-30 02:25 2020-01-27 PBF PBF Energy Inc. Inversora Carso, S.A. de C.V. 10% owner, Other Petroleum Refining BUY $26.79 200,000 $5,357,380 21,332,430 +0.9%
2020-01-28 22:34 2019-11-27 N-A N/A LEGG MASON, INC. 10% owner, Other Other BUY $10.11 98,912 $1,000,000 2,128,912 +4.9%
2020-01-28 22:29 2019-09-04 N-A N/A LEGG MASON, INC. 10% owner, Other Other BUY $10.00 2,020,000 $20,200,000 2,030,000 +20,200.0%
2020-01-29 00:39 2020-01-24 IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $136.00 81,100 $11,029,722 20,706,233 +0.4%
2020-01-29 00:52 2020-01-24 ADAP Adaptimmune Therapeutics PLC Behbahani Ali Director Biological Products, (No Diagnostic Substances) BUY $0.67 7,500,000 $5,000,250 19,500,000 +62.5%
2020-01-29 00:52 2020-01-24 ADAP Adaptimmune Therapeutics PLC Florence Anthony A. Jr. 10% owner Biological Products, (No Diagnostic Substances) BUY $0.67 7,500,000 $5,000,250 19,500,000 +62.5%
2020-01-29 00:55 2020-01-24 ADAP Adaptimmune Therapeutics PLC Sonsini Peter W. 10% owner Biological Products, (No Diagnostic Substances) BUY $0.67 7,500,000 $5,000,250 19,500,000 +62.5%
2020-01-28 19:16 2020-01-24 PPR Saba Capital Income & Opportunities Fund Saba Capital Management, L.P. 10% owner Other BUY $5.12 352,479 $1,804,692 29,536,023 +1.2%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.